Table 2.
Results of the measurement of relaxation and of randomization energy, Er
| Healthy | SAR | FIB | COB | |
| N | 17 | 15 | 12 | 19 |
| Ar_s | 0.76 +/- 0.04 | 0.79 +/- 0.03 (**) | 0.79 +/- 0.07 (ns) | 0.75 +/- 0.06 (ns) |
| Tr_f, s | 20.6 +/- 7.0 | 14.5 +/- 3.8 (**) | 14.2 +/- 5.6 (**) | 16.9 +/- 5.4 (ns) |
| Tr_s | 259 +/- 61 | 257 +/- 39 (ns) | 221 +/- 47 (ns) | 239 +/- 57 (ns) |
| Tr_a, s | 66.1 +/- 16.3 | 57.5 +/- 9.1 (ns) | 50.2 +/- 12.5 (**) | 55.7 +/- 14.5 (*) |
| b1 | 0.61 +/- 0.05 | 0.63 +/- 0.02 (ns) | 0.60 +/- 0.04 (ns) | 0.59 +/- 0.07 (ns) |
| b5 | 0.23 +/- 0.07 | 0.24 +/- 0.04 (ns) | 0.20 +/- 0.06 (ns) | 0.21 +/- 0.07 (ns) |
| Er, 10-18 J | 6.0 +/- 2.1 | 4.6 +/- 1.5 (*) | 5.2 +/- 2.6 (ns) | 5.4 +/- 3.1 (ns) |
Data are presented as mean +/- SD; SAR: patients with sarcoidosis, IPF: patients with idiopathic pulmonary fibrosis, COB: patients with chronic obstructive bronchitis, N: number of subjects, parameters of the two-term exponential relaxation model: Ar_s: fraction of slow decay, Tr_f: time constant of fast decay, Tr_s: time constant of slow decay, Tr_a: time constant of initial decay; b1: normalized decay after 1 min.; b5: normalized decay after 5 min.; Er: cell energy; ns: not significant; *: p < 0.05, **: p < 0.01).